Form 8-K - Current report:
SEC Accession No. 0000950170-22-000621
Filing Date
2022-02-01
Accepted
2022-02-01 07:59:26
Documents
14
Period of Report
2022-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pali-20220131.htm   iXBRL 8-K 54240
2 EX-4.1 pali-ex4_1.htm EX-4.1 367426
3 EX-4.2 pali-ex4_2.htm EX-4.2 216207
  Complete submission text file 0000950170-22-000621.txt   850991

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pali-20220131.xsd EX-101.SCH 2504
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pali-20220131_pre.xml EX-101.PRE 10002
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pali-20220131_lab.xml EX-101.LAB 13562
8 EXTRACTED XBRL INSTANCE DOCUMENT pali-20220131_htm.xml XML 4735
Mailing Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008
Business Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 22576912
SIC: 2836 Biological Products, (No Diagnostic Substances)